Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study.

ABSTRACT:

Background

Dialysis confers the highest risk of coronavirus disease 2019 (COVID-19) death among comorbidities predisposing to severe COVID-19. However, reports of COVID-19-associated mortality frequently refer to mortality during the initial hospitalization or first month after diagnosis.

Methods

In a prospective, observational study, we analysed the long-term (1-year follow-up) serological and clinical outcomes of 56 haemodialysis (HD) patients who were infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first pandemic wave. COVID-19 was diagnosed by a positive polymerase chain reaction (PCR) test (n = 37) or by the development of anti-SARS-CoV-2 antibodies (n = 19).

Results

After >1 year of follow-up, 35.7% of HD patient

SUBMITTER: Carriazo S 

PROVIDER: S-EPMC8755355 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature